4
Changes in Ownership
Adaptimmune Therapeutics PLC Filed Acc 0001104659-20-101976
Chief Executive Officer sold 2,776 shares at $8.51 ($23,637)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rawcliffe Adrian Chief Executive Officer | 2020-09-01 | Sale | −2,776 | $8.51 | $23,637 | 3,076 | D |
| Open-market sales · 2,776 sh · avg $8.51 · $23,637 | |||||||
Loading xslF345X03/a4.xml…